Unfortunately Wayne's head is directly in front of the patient population info. Part we can see mentions bench testing of a 25mm valve and jet reduction (sewing only).
If it's for valve in valve, we will likely need to target a specific subset of patients needing that procedure because the humanitarian device exemption is limited by law to a condition that affects not more than 8,000 per year in the US. According to Anteris' projections, the number of TAVR procedures is expected to be over 100,000 in the US in 2024 and Dr Meduri said that he expects valve in valve to grow to 30-40% in 5-6 years so the general valve in valve market may be too large.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)